Vimarsana
Biggest News Aggregation in the World

Page 5 - Associate Scientist News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Associate Scientist. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Associate Scientist Today - Breaking & Trending Today

Faecal transplants show potential to improve melanoma treatment: Study - Vimarsana News

Faecal transplants show potential to improve melanoma treatment: Study

A multi-centre study from Lawson Health Research Institute, the Centre Hospitalier de lUniversite de Montreal (CHUM), and the Jewish General Hospital (JGH) fou

Unique blood protein patterns in long COVID patients could reveal potential drug targets - Vimarsana News

Unique blood protein patterns in long COVID patients could reveal potential drug targets

Recently published in The Journal of Translational Medicine, a team at Lawson Health Research Institute has discovered unique patterns of blood plasma proteins in patients with long COVID that could reveal potential drug targets to improve patient outcomes.

Blood Plasma Proteins Can Better Explain Long Covid: Study - Vimarsana News

Blood Plasma Proteins Can Better Explain Long Covid: Study

Toronto, July 8 (IANS) Canadian researchers have discovered unique patterns of blood plasma proteins in patients with suspected long Covid that could act as a

Blood plasma proteins can better explain long Covid: Study - Vimarsana News

Blood plasma proteins can better explain long Covid: Study

Canadian researchers have discovered unique patterns of blood plasma proteins in patients with suspected long Covid that could act as a potential drug target to improve patient outcomes.Currently, approximately 10-20 per cent of people with a ...

Fecal transplants safe and effective in treating advanced melanoma, clinical trial shows - Vimarsana News

Fecal transplants safe and effective in treating advanced melanoma, clinical trial shows

In a world-first clinical trial published in the journal Nature Medicine, a multi-center study from Lawson Health Research Institute, the Centre hospitalier de l'Université de Montréal and the Jewish General Hospital (JGH) has found fecal microbiota transplants (FMT) from healthy donors are safe and show promise in improving response to immunotherapy in patients with advanced melanoma.